Condition: Epilepsy, Temporal Lobe · Sponsor: Neurona Therapeutics
This is a multicenter, single arm, open label clinical trial that is designed to test the safety and preliminary efficacy of single administration inhibitory nerve cells called interneurons (NRTX-1001), into both temporal lobes of subjects with drug-resistant bilateral mesial temporal lobe epilepsy.
This description comes directly from the study's public registry record.
Neurona MedInfo · 650-580-3825 · neuronamedinfo@neuronatx.com
Eduardo Dunayevich, MD · 650-436-3045 · edunayevich@neuronatx.com
Always discuss trial participation with your own doctor first.
| University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | Recruiting |
| University of Southern California Keck Hospital | Los Angeles, California, United States | Recruiting |
| UC Irvine Medical Center | Orange, California, United States | Recruiting |
| Stanford University | Palo Alto, California, United States | Recruiting |
| University of California San Diego | San Diego, California, United States | Recruiting |
| University of California San Francisco | San Francisco, California, United States | Withdrawn |
| University of Colorado Anschutz Medical Campus | Aurora, Colorado, United States | Recruiting |
| University of Chicago | Chicago, Illinois, United States | Recruiting |
| University of Iowa Health Care | Iowa City, Iowa, United States | Recruiting |
| SUNY Upstate Medical University | Syracuse, New York, United States | Recruiting |
| Atrium Health | Charlotte, North Carolina, United States | Recruiting |
| Duke University Hospital | Durham, North Carolina, United States | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06422923